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Limb-threatening ischemia often results when a
distal tibial bypass graft fails and circulation cannot be
restored by means of revision, lytic therapy, or a new
distal bypass graft. The presence of an isolated
popliteal artery that could still be used for limb salvage
may be overlooked, or an isolated femoropopliteal
bypass grafting procedure may not be performed
because of prejudice against this procedure.
Eight secondary isolated popliteal bypass graft-
ing procedures were performed after failed tibial
reconstructions, and the results for these secondary
bypass grafts were compared with those of 42 pri-
mary bypass grafts to isolated popliteal arteries.
METHOD AND RESULTS
General experience with isolated femoro-
popliteal bypass grafts. Arteriographic evaluation
and color duplex scans preceded all isolated
femoropopliteal bypass grafts (IFPBs). These grafts
were only constructed if the uninvolved or patent
popliteal segment measured at least 7 cm in length and
had at least one major collateral supplying the calf. The
position of the isolated segment above or below the
knee did not impact the decision to use that vessel.
Primary isolated femoropopliteal bypass
grafts. Primary IFPBs constituted 8.5% of the
femoropopliteal bypass grafting procedures per-
formed by our group. The indications for primary
IFPB were gangrene in 13 patients (31%), nonheal-
ing ulceration in 12 patients (29%), rest pain in eight
patients (19%), and claudication in nine patients
(21%). Primary IFPB was usually performed only
when gangrene or nonhealing ulceration was limited
to the digits or a small portion of the heel or foot
(usually patches of less than 1 cm). The mean age of
the patients was 72 years (range, 46 to 90 years).
Twenty-five of the patients were men (60%), and 17
were women (40%). As in our general population of
infrainguinal reconstructions, most patients had co-
morbid conditions, such as diabetes in 35 patients
(83%), coronary artery disease in 26 patients (62%),
hypertension in 17 patients (40%), and a history of
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Purpose: Femoropopliteal bypass grafting procedures performed to isolated popliteal
arteries after failure of a previous tibial reconstruction were studied. The results were
compared with those of a study of primary isolated femoropopliteal bypass grafts
(IFPBs).
Methods: IFPBs were only constructed if the uninvolved or patent popliteal segment mea-
sured at least 7 cm in length and had at least one major collateral supplying the calf.
When IFPB was performed for ischemic lesions, these lesions were usually limited to the
digits or small portions of the foot. Forty-seven polytetrafluoroethylene grafts and three
autogenous reversed saphenous vein grafts were used. 
Results: Ankle brachial pressure index (ABI) increased after bypass grafting by a mean of
0.46. Three-year primary life table patency and limb-salvage rates for primary IFPBs
were 73% and 86%, respectively. All eight IFPBs performed after failed tibial bypass
grafts remained patent for 2 to 44 months, with patients having viable, healed feet.
Conclusion: In the presence of a suitable popliteal artery and limited tissue necrosis,
IFPB can have acceptable patency and limb-salvage rates, even when a polytetrafluo-
roethylene graft is used. Secondary IFPB can be used to achieve limb salvage after failed
tibial bypass grafting. (J Vasc Surg 1999;29:409-12.)
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smoking in 32 patients (76%). The IFPB grafts were
constructed to the above-knee segment in 23
patients (55%) and the below-knee segment in 19
patients (45%).
For the primary IFPB, 39 (93%) expanded poly-
tetrafluoroethylene (PTFE) grafts and three (7%)
reversed autogenous saphenous veins were used. This
preponderance of PTFE results from our bias of
using a prosthetic graft to the popliteal, thus saving
the vein for possible future distal bypass graft. When
PTFE was used, adjunctive measures such as vein
cuffs or arteriovenous fistulae were not added.
Warfarin anticoagulation was also not prescribed for
any patients undergoing IFPB. All patients were care-
fully followed up with six monthly clinical, duplex,
and plethysmographic evaluations, and data was ana-
lyzed by means of the Atrium Registry database.
Some degree of hemodynamic improvement was
noted in all patients (D Ankle brachial pressure index
[ABI] of 0.19 to 1.0; mean, 0.46). The mean D ABI
increase was less than the mean D ABI of 0.61 seen in
bypass grafts to nonisolated popliteal arteries with at
least one vessel runoff (P < .05).
Three-year primary life table patency and limb-
salvage rates for the 42 primary PTFE IFPBs were
73% and 86%, respectively. The location of the distal
anastomosis (above or below the knee) did not affect
the patency and limb-salvage rates. Arteriograms
have been reviewed to assess whether there was a dif-
ference in outcome based on the runoff visualized
below the isolated popliteal artery. In six patients, no
named artery could be continuously visualized into
the foot. However, collateral vessels extending to
the foot or discontinuous major tibial arteries were
shown by means of the arteriograms. Two of the
IFPBs constructed in these patients failed with time
(not acutely). In the remaining 36 patients, at least
one leg artery suitable for bypass grafting was iden-
tified (peroneal, 56%; anterior tibial, 32%; and pos-
terior tibial, 16%). Seven of the IFPB bypass grafts
(20%) failed in this group; three of these failures
occurred within 30 days.
Three patients required a subsequent reversed
saphenous vein extension of the bypass graft to a tib-
ial artery to heal gangrene that was unresponsive to
the original IFPB. There were no operative mortali-
ties. However, eight patients (19%) died within 3
years of surgery.
In a similar period, we performed 142 primary
and secondary tibial and pedal bypass grafts with
reversed saphenous, in situ, and arm veins. The pri-
mary patency rate at 3 years was 71%, the secondary
or assisted patency rate was 82%, and the limb salvage
rate was 91%. Our experience with IFPB can also be
compared with our overall experience with 588
femoropopliteal bypass grafts (above- and below-
knee) with at least one vessel runoff and using various
graft materials, in which the 3-year primary patency
rate was 78% and the limb salvage rate was 93%.
Secondary isolated femoropopliteal bypass
graft. The original distal tibial reconstructions (one
posterior tibial, three anterior tibial, and four pero-
neal) were performed for limb-threatening ischemia
in all eight patients. Seven original procedures were
performed at other institutions, and, accordingly, the
degree of distal ischemia could only be ascertained by
chart review and the patients’ recollection of their
foot’s appearance at the time of the original opera-
tion. Six patients had nonhealing ulcers (four on the
toe and two on the heel). Two patients had gangrene
limited to the tip of a digit. All patients had rest pain.
All original bypass grafts were constructed with ipsi-
lateral reversed saphenous veins, and all achieved
healing. Ultimately, however, these bypass grafts
failed, and distal ischemic lesions recurred (three
cases of gangrene of the tip of one toe and five cases
of small [less than 1 cm] nonhealing foot or heel
ulcers). ABIs ranged from 0 to 0.35. All eight
patients were diabetic, and six were active smokers.
Another tibial artery was demonstrated to be
suitable for a new distal bypass graft by means of
routine angiography in two patients. However, nei-
ther patient had a sufficient useable vein for such a
bypass graft. Both patients had undergone earlier
coronary artery bypass grafting, and the remnant
lesser saphenous and arm veins were too small. The
other six patients did not have any named distal
arteries. Isolated popliteal segments 7 cm or longer
with at least one sural collateral were demonstrated
in all eight patients.
Based on our previous experience with primary
bypass grafts to an isolated popliteal segment, we
elected to perform the bypass grafting procedures as
secondary procedures in these eight patients (six
above-knee and two below-knee). PTFE (four
Goretex and four Atrium) was used for all eight grafts.
Despite the limited outflow, all grafts remained patent
(at follow-up examinations after 2, 2, 3, 7, 18, 32, 42,
or 44 months). All pedal lesions healed, and rest pain
was eliminated. ABI was improved by at least 0.25 in
all patients ( D ABI = 0.25, 0.27, 0.33, 0.34, 0.36,
0.42, 0.5, 0.7).
DISCUSSION
Principles of revascularization for limb-threaten-
ing ischemia have become well established. In gen-
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eral, the most proximal lesions are treated first, sav-
ing a distal procedure for failure of the more proxi-
mal operation. In infrainguinal reconstructions, this
may mean performing a femoropopliteal bypass
grafting procedure as the primary procedure. Distal
tibial bypass grafting would then be performed only
when the first procedure failed to heal the foot or
when the femoropopliteal bypass graft ultimately
failed and patency could not be restored by means of
thrombectomy or lytic therapy. Performing a more
proximal femoropopliteal bypass grafting procedure
with a prosthetic, such as a PTFE graft, also has the
benefit of saving the saphenous vein for the distal
bypass graft, in which patency rates are appreciably
lower with prosthetic grafts. In keeping with this
philosophy, bypass grafting to so-called “blind” or
isolated popliteal arteries has been proposed to be an
effective primary procedure for infrainguinal revas-
cularization.1-7,9 Veith et al2 demonstrated that if the
popliteal artery was at least 7 cm long and had
demonstrable collaterals, acceptable patency rates
could be achieved. Mannick et al1 and Veith et al2,9
have shown that patency rates of 70% may equal the
more privileged situation seen when more than one
patent runoff artery is present. We have confirmed
similar findings in our own patients. Three-year life
table patency and limb-salvage rates for our isolated
femoropopliteal bypass grafts were 73% and 86%,
respectively. This compares favorably with our over-
all experience with femoropopliteal bypass grafts
(above- and below-knee) with at least one vessel
runoff and using various graft materials, in which the
3-year primary patency rate was 78% and the limb-
salvage rate was 93%.
Veith et al2 and Kram et al9 demonstrated
acceptable patency and limb salvage with prosthetic
grafts, especially when the above-knee popliteal was
the outflow artery. Corson et al3 suggested that
PTFE did not perform well for isolated popliteal
bypass grafts (17% 5-year patency rate, compared
with 65% for veins). However, they included only 14
synthetic grafts in their series of 65 IFPBs, five of
which were not PTFE and two of which were com-
posite grafts that failed within 5 months of surgery.
With the advances in infrainguinal reconstruc-
tions that have occurred in the last decade, the value
of IFPB has again come into question. A dilemma
exists between performing an IFPB or a bypass graft
to a more distal tibial artery when revascularization
is to be performed for rest pain or minimal tissue
necrosis.9 Most surgeons may prefer to proceed
directly to tibial bypass grafting. Excellent patency
rates achieved with such grafts and the improved
hemodynamic results that can be expected will usu-
ally result in just one procedure being necessary.
However, our preference has been to proceed with
an IFPB if the popliteal is suitable. This can later be
extended to the more distal tibial artery, if one is
available and if the IFPB fails to achieve healing. In
part, our preference is based on similar patency rates
achieved by our group with isolated femoropopliteal
grafts and tibial bypass grafts. Within a similar peri-
od, we performed 142 tibial and pedal bypass grafts
with reversed saphenous, in situ, and arm veins. The
primary patency rate at 3 years follow-up was 71%,
the secondary or assisted patency rate was 82%, and
the limb-salvage rate was 91%. Using a prosthetic
graft for the IFPB often preserves what little vein is
available for use in the tibial bypass graft. Such an
extension was rarely required in our patients (three
of 42, 7%), and no patient had a totally new tibial
bypass graft because of failure to heal. Kram et al9
were required to perform such additional tibial
bypass grafts in only 11% of patients in their larger
series. An IFPB with a prosthetic graft allows for a
quick initial surgery, which may account for the low
(0%) operative mortality rate seen in our patients. It
should be noted that in Kram’s review the operative
mortality rate was higher (10%). However, it did not
differentiate whether deaths were more common in
IFPB performed with vein or PTFE. It is believed
that the longer operative time required for vein har-
vest may increase operative morbidity and mortality.
There are occasions, however, when a bypass graft
to the popliteal will not be constructed as the first pro-
cedure. Bypass grafts to isolated popliteal arteries may
not be effective when significant limb-threatening
lesions affect the foot. In such circumstances, even
when the bypass graft stays patent, distal hemodynam-
ics often do not improve sufficiently to result in heal-
ing.2,6,10 In our patient population, D ABI increased by
a mean of only 0.46, compared with 0.61 in patients
undergoing bypass grafting to nonisolated popliteal
arteries. Accordingly, in the presence of significant
pedal ischemia, primary distal bypass grafting may be
preferable, even when an “acceptable” isolated
popliteal artery is present. Furthermore, many sur-
geons do not perform IFPB, opting instead for a pri-
mary distal tibial bypass graft.1-9 In such circum-
stances, the isolated popliteal artery may still be avail-
able for use as an outflow vessel if the primary distal
reconstruction fails. Recognition of such an available
artery may allow for insertion of a secondary isolated
popliteal graft and limb salvage. Such an approach may
be especially useful when an original tibial bypass graft
improves the distal ischemia sufficiently so that only a
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modest increase in perfusion is required. Secondary
isolated popliteal bypass grafts are also attractive
because usually the ipsilateral saphenous vein will have
been used for the original tibial bypass graft.
Accordingly, only limited remnants of vein may be
available. These could be used for a short isolated
popliteal bypass graft or jump graft extension from a
prosthetic IFPB, but may not be long enough for an
entirely new distal procedure. Furthermore, if vein is
not available, PTFE can be used for a graft to the
popliteal.
CONCLUSION
Controversy still exists about which procedure is
best suited for revascularization in the presence of
limited tissue necrosis or rest pain. Even when an
isolated popliteal artery is present, many surgeons
will favor direct tibial bypass grafting. However, in
these conditions, we believe that our approach of
primarily selecting the isolated popliteal for the dis-
tal anastomosis results in acceptable patency, limb-
salvage, and mortality rates, without increasing the
need for secondary procedures.
Our experience with eight patients also demon-
strates that secondary IFPBs can be used to achieve
limb salvage after failed tibial bypass grafting. Good
results can be achieved, even with the use of PTFE,
provided that extensive pedal tissue necrosis is not
present.
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